| Lastest Insider Transactions Of Voyager Therapeutics, Inc. ( VYGR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2024-04-02 | Sell | 1,357 | 9.88 | 13,407 | 2024-04-03 16:13:27 |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | 2024-04-02 | Sell | 12,115 | 9.86 | 119,454 | 2024-04-03 16:10:41 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2024-02-21 | Sell | 3,966 | 7.45 | 29,547 | 2024-02-22 16:36:22 |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | 2024-02-21 | Sell | 13,033 | 7.46 | 97,226 | 2024-02-22 16:34:47 |
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | 2024-02-21 | Sell | 3,764 | 7.46 | 28,079 | 2024-02-22 16:32:59 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2024-02-20 | Sell | 3,967 | 7.50 | 29,760 | 2024-02-22 16:30:55 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2024-01-17 | Sell | 2,543 | 7.15 | 18,182 | 2024-01-19 16:34:25 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2024-01-17 | Sell | 1,266 | 7.18 | 9,090 | 2024-01-19 16:32:36 |
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | 2023-10-03 | Sell | 13,567 | 6.99 | 94,833 | 2023-10-05 16:41:46 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-09-15 | Sell | 10,500 | 8.16 | 85,680 | 2023-09-18 16:44:19 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-09-15 | Option Exercise | 5,000 | 2.85 | 14,250 | 2023-09-18 16:44:19 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-07-06 | Sell | 5,500 | 10.80 | 59,400 | 2023-07-10 16:42:44 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-06-30 | Sell | 5,000 | 11.41 | 57,050 | 2023-07-05 16:32:21 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-06-30 | Option Exercise | 5,000 | 2.85 | 14,250 | 2023-07-05 16:32:21 |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | 2023-04-03 | Sell | 7,437 | 7.83 | 58,232 | 2023-04-05 17:04:43 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2023-04-03 | Sell | 1,259 | 7.83 | 9,858 | 2023-04-05 17:02:30 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-03-20 | Sell | 2,193 | 7.76 | 17,018 | 2023-03-22 16:49:34 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2023-03-20 | Sell | 3,654 | 7.76 | 28,355 | 2023-03-22 16:48:39 |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | 2023-03-20 | Sell | 4,410 | 7.76 | 34,222 | 2023-03-22 16:47:41 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2023-03-15 | Sell | 15,373 | 8.20 | 126,059 | 2023-03-17 16:37:20 |
| VYGR | Voyager Therapeutics, Inc. | NEUROCRINE BIOSCIENCES INC | 10% Owner | 2023-02-23 | Buy | 4,395,588 | 8.88 | 39,032,820 | 2023-02-24 06:15:24 |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | 2023-02-17 | Sell | 3,297 | 7.45 | 24,563 | 2023-02-22 20:58:28 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-02-17 | Sell | 738 | 7.45 | 5,498 | 2023-02-22 20:57:32 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-02-13 | Sell | 797 | 7.67 | 6,113 | 2023-02-15 16:53:30 |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | 2023-02-13 | Sell | 2,868 | 7.67 | 21,998 | 2023-02-15 16:52:12 |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% Owner | 2023-01-30 | Sell | 388,642 | 9.23 | 3,587,444 | 2023-02-01 19:26:33 |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% Owner | 2023-01-27 | Sell | 50,000 | 9.02 | 451,000 | 2023-01-31 16:30:16 |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% Owner | 2023-01-24 | Sell | 150,000 | 9.25 | 1,388,000 | 2023-01-26 17:23:06 |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% Owner | 2023-01-20 | Sell | 155,000 | 9.12 | 1,413,300 | 2023-01-24 18:20:44 |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | 2023-01-17 | Sell | 2,188 | 9.85 | 21,549 | 2023-01-19 16:57:23 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-01-17 | Sell | 1,106 | 9.85 | 10,892 | 2023-01-19 16:55:14 |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | 2023-01-17 | Sell | 2,188 | 9.85 | 21,549 | 2023-01-19 16:53:41 |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | 2023-01-09 | Sell | 902,400 | 7.91 | 7,142,343 | 2023-01-11 18:26:21 |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | 2023-01-06 | Sell | 388 | 6.41 | 2,487 | 2023-01-10 16:07:34 |
